Hiroaki Ito

4.0k total citations · 1 hit paper
53 papers, 1.9k citations indexed

About

Hiroaki Ito is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Hiroaki Ito has authored 53 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 24 papers in Epidemiology and 13 papers in Immunology. Recurrent topics in Hiroaki Ito's work include Inflammatory Bowel Disease (30 papers), Microscopic Colitis (21 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Hiroaki Ito is often cited by papers focused on Inflammatory Bowel Disease (30 papers), Microscopic Colitis (21 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Hiroaki Ito collaborates with scholars based in Japan, United States and France. Hiroaki Ito's co-authors include Mitsunari Yamamoto, Tadamitsu Kishimoto, Kazuyuki Yoshizaki, Toshifumi Hibi∥, Jessica A. Hamerman, Takayuki Matsumoto, Masakazu Takazoe, Akira Andoh, Yoshihiro Fukuda and Kazuo Kusugami and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Hiroaki Ito

49 papers receiving 1.9k citations

Hit Papers

A pilot randomized trial of a human anti-interleukin-6 re... 2004 2026 2011 2018 2004 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease☆
    2004 507 citations Hiroaki Ito, Masakazu Takazoe et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Ito Japan 20 858 845 561 303 261 53 1.9k
Sebastian Zundler Germany 23 760 0.9× 1.0k 1.2× 394 0.7× 295 1.0× 357 1.4× 85 1.9k
Sanae Fujino Japan 9 708 0.8× 1.4k 1.7× 345 0.6× 306 1.0× 335 1.3× 10 2.1k
Julia Diegelmann Germany 21 598 0.7× 832 1.0× 327 0.6× 196 0.6× 271 1.0× 31 1.5k
Gail West United States 28 1.2k 1.4× 1.1k 1.3× 588 1.0× 415 1.4× 757 2.9× 65 3.0k
Anna Šedivá Czechia 30 533 0.6× 1.4k 1.7× 331 0.6× 156 0.5× 515 2.0× 124 2.7k
MF Neurath Germany 22 815 0.9× 920 1.1× 653 1.2× 479 1.6× 397 1.5× 72 2.6k
Atsuhiro Ogaẃa Japan 19 524 0.6× 1.2k 1.4× 296 0.5× 380 1.3× 591 2.3× 56 2.3k
Dror S. Shouval Israel 19 539 0.6× 882 1.0× 349 0.6× 423 1.4× 727 2.8× 92 2.1k
Gencheng Han China 31 286 0.3× 1.6k 1.9× 337 0.6× 439 1.4× 634 2.4× 115 2.5k
George P. Christophi United States 18 277 0.3× 583 0.7× 263 0.5× 174 0.6× 525 2.0× 34 1.4k

Countries citing papers authored by Hiroaki Ito

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Ito more than expected).

Fields of papers citing papers by Hiroaki Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Ito. The network helps show where Hiroaki Ito may publish in the future.

Co-authorship network of co-authors of Hiroaki Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Ito. A scholar is included among the top collaborators of Hiroaki Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Ito. Hiroaki Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Tatsumi, Yoshihiro, Kazuki Kakimoto, Azusa Hara, et al.. (2023). Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis. Journal of Clinical Medicine. 12(22). 7165–7165. 5 indexed citations
5.
Kawabata, Hiroshi, Jun Kato, Hiroaki Ito, et al.. (2022). Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study. International Journal of Hematology. 116(6). 846–855. 2 indexed citations
6.
Shinzaki, Shinichiro, et al.. (2021). Nurse-Provided Medication Guidance for Improving Drug Adherence to Thiopurines in Outpatients With Inflammatory Bowel Disease: A Single-Center Prospective Study. Crohn s & Colitis 360. 4(1). otab081–otab081. 1 indexed citations
7.
Kobayashi, Taku, Hiroaki Ito, Toshifumi Ashida, et al.. (2020). Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis. Intestinal Research. 19(4). 448–460. 10 indexed citations
8.
Yamagishi, Takuya, Mari Matsui, Tsuyoshi Sekizuka, et al.. (2020). A prolonged multispecies outbreak of IMP-6 carbapenemase-producing Enterobacterales due to horizontal transmission of the IncN plasmid. Scientific Reports. 10(1). 4139–4139. 27 indexed citations
9.
10.
11.
Hibi∥, Toshifumi, Atsushi Sakuraba, Mamoru Watanabe, et al.. (2013). C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn’s disease. Journal of Gastroenterology. 49(2). 254–262. 50 indexed citations
12.
Ito, Hiroaki, Mitsuo Iida, Takayuki Matsumoto, et al.. (2010). Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: A double-blind, randomized study. Inflammatory Bowel Diseases. 16(9). 1567–1574. 63 indexed citations
13.
Esashi, Eiji, Hiroaki Ito, Ken‐ichi Minehata, et al.. (2009). Oncostatin M deficiency leads to thymic hypoplasia, accumulation of apoptotic thymocytes and glomerulonephritis. European Journal of Immunology. 39(6). 1664–1670. 24 indexed citations
14.
Ito, Hiroaki, et al.. (2009). Pharmacokinetics and safety of single and multiple doses of Asacol tablets in Japanese healthy volunteers. Advances in Therapy. 26(8). 749–761. 8 indexed citations
15.
Matsumoto, Takayuki, Mitsuo Iida, Satoshi Motoya, et al.. (2008). Therapeutic Efficacy of Infliximab on Patients with Short Duration of Crohn's Disease: A Japanese Multicenter Survey. Diseases of the Colon & Rectum. 51(6). 916–923. 14 indexed citations
16.
Ito, Hiroaki, Eiji Esashi, Taishin Akiyama, Jun‐ichiro Inoue, & Atsushi Miyajima. (2006). IL-18 produced by thymic epithelial cells induces development of dendritic cells with CD11b in the fetal thymus. International Immunology. 18(8). 1253–1263. 8 indexed citations
17.
Ito, Hiroaki, Masakazu Takazoe, Yoshihiro Fukuda, et al.. (2004). A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease☆. Gastroenterology. 126(4). 989–996. 507 indexed citations breakdown →
18.
Ito, Hiroaki, Tomonori Hirotani, Mitsunari Yamamoto, Hiroyuki Ogawa, & Tadamitsu Kishimoto. (2002). Anti-IL-6 receptor monoclonal antibody inhibits leukocyte recruitment and promotes T-cell apoptosis in a murine model of Crohn’s disease. Journal of Gastroenterology. 37(S14). 56–61. 36 indexed citations
19.
Kaneko, Kazuhiro, et al.. (2001). Prospective randomised treatment trial of argon plasma coagulation and topical formalin for radiation proctitis. Gastrointestinal Endoscopy. 53(5). AB184–AB184. 3 indexed citations
20.
Yamamoto, Mitsunari, Kazuyuki Yoshizaki, Tadamitsu Kishimoto, & Hiroaki Ito. (2000). IL-6 Is Required for the Development of Th1 Cell-Mediated Murine Colitis. The Journal of Immunology. 164(9). 4878–4882. 353 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastian Zundler Breakdown of academic impact, for papers by Sanae Fujino Breakdown of academic impact, for papers by Julia Diegelmann Breakdown of academic impact, for papers by Gail West Breakdown of academic impact, for papers by Anna Šedivá Breakdown of academic impact, for papers by MF Neurath Breakdown of academic impact, for papers by Atsuhiro Ogaẃa Breakdown of academic impact, for papers by Dror S. Shouval Breakdown of academic impact, for papers by Gencheng Han Breakdown of academic impact, for papers by George P. Christophi
Rankless by CCL
2026